Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Oscar, Alexander H
UplighTED, NCT06307613: A Study of Efgartigimod PH20 SC Given by Prefilled Syringe in Adults with Thyroid Eye Disease	Recruiting	3	108	Europe, US, RoW	Efgartigimod PH20 SC, Placebo PH20 SC	argenx	Thyroid Eye Disease	02/26	10/27
NCT04740671 / 2020-005364-57: A Phase 3 Study to Compare the Efficacy and Safety of HLX04-O with Ranibizumab in Subjects with WAMD	Completed	3	410	Europe, US, RoW	HLX04-O, ranibizumab	Shanghai Henlius Biotech	Age Related Macular Degeneration	12/24	12/24
EU-ROP, NCT04939571: European Disease Registry on Retinopathy of Prematurity (ROP)	Recruiting	N/A	3000	Europe, RoW	Registry of preterm born infants with treatment-requiring ROP	University Medicine Greifswald	Retinopathy of Prematurity	08/38	08/39